Cargando…
Downregulation of CacyBP by CRISPR/dCas9-KRAB Prevents Bladder Cancer Progression
Bladder cancer (BCa) is a leading cause of cancer-related death in the world. CacyBP is initially described as a binding partner of calcyclin and has been shown to be involved in a wide range of cellular processes, including cell differentiation, proliferation, protein ubiquitination, cytoskeletal d...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226165/ https://www.ncbi.nlm.nih.gov/pubmed/34179100 http://dx.doi.org/10.3389/fmolb.2021.692941 |